Intranasal Bioavailability

Intranasal Bioavailability is the fraction of an administered drug that reaches systemic circulation following intranasal administration, serving as a quantitative measure of the extent and rate of absorption specific to the nasal mucosal route.

203

Publications

8.6K

Citations

911

Authors

305

Institutions

Publications per year

2017–2026

45

Authors

911

  1. EB
    Erik Bechgaard

    Schools of Visual Arts, The Royal Danish Academy of Fine Arts, Denmark

    7 publications · 171 citations

    7

    h-index

  2. DP
    Daniel P. Wermeling

    University of Kentucky, United States

    6 publications · 154 citations

    6

    h-index

  3. SM
    Shirui Mao

    Shenyang Pharmaceutical University, China

    6 publications · 231 citations

    6

    h-index

  4. JC
    James C. Cloyd

    University of Minnesota, United States

    5 publications · 164 citations

    5

    h-index

  5. AF
    A.N. Fisher

    University of Nottingham, United Kingdom

    4 publications · 296 citations

    4

    h-index

1–5 of 911

Venues

  1. International Journal of Pharmaceutics

    19 publications · 710 citations

    16

    h-index

  2. Journal of Pharmacy and Pharmacology

    JPP · 11 publications · 589 citations

    11

    h-index

  3. Journal of Pharmaceutical Sciences

    11 publications · 309 citations

    10

    h-index

  4. Pharmaceutical Research

    9 publications · 276 citations

    9

    h-index

  5. Pharmaceutics

    6 publications · 193 citations

    6

    h-index

1–5